基于acros的肺SBRT密度覆盖规划与动态适形弧技术:与基于aaa的四维剂量规划的比较评价

I. Yeo, N. Joyce, Deepinder P. Singh, M. Milano, Yuhchyau Chen, Sanjukta Bandyopadhyay, Hongmei Yang, D. Rosenzweig
{"title":"基于acros的肺SBRT密度覆盖规划与动态适形弧技术:与基于aaa的四维剂量规划的比较评价","authors":"I. Yeo, N. Joyce, Deepinder P. Singh, M. Milano, Yuhchyau Chen, Sanjukta Bandyopadhyay, Hongmei Yang, D. Rosenzweig","doi":"10.4236/IJMPCERO.2021.102009","DOIUrl":null,"url":null,"abstract":"The purpose of this study was to evaluate a planning \nstrategy based on Acuros with density override in comparison with AAA without \nand with the override. Ten lung-tumor patients were selected with each PTV size \naround 2 - 4 cm and were imaged using slow scan, followed by four-dimensional \n(4D) imaging limited to the target. On each \nphase-specific image, gross tumor volume (GTV) was contoured. Summed \nover all phases, an integrated GTV (iGTV) was generated and copied to the slow \nscan. A treatment plan was created using a dynamic-conformal-arc technique with \nAAA to prescribe 60 Gy to 95% of PTV (iGTV + 0.5 cm). Each AAA-based plan was \nregenerated by overriding the density of the setup margin of PTV by GTV density \n(modeling tumor-position uncertainty). It was also regenerated with Acuros and \nthe override. The three plans were validated in 4D dose to PTV, after similarly \noverriding PTV density (phase-specific), accurately calculating with Acuros, \nand summing the phase-specific plans through organ/dose registration. The \nAcuros-based plan with the override, the AAA-based plan, and the AAA-based plan \nwith the override provided 4D PTV doses of 63.9, 67.9, and 62 Gy at D95%, \nrespectively, averaged over all patients. The override with Acuros and AAA \nproduced lesser 4D doses, closer to the associated 3D doses, respectively, than \nthat without the override, with better conformity and inhomogeneity. With the \noverride in common, Acuros provided a greater dose to PTV than that by AAA. The \nAcuros with the override, which was more accurate than the AAA without the \noverride, is clinically recommended.","PeriodicalId":14028,"journal":{"name":"International Journal of Medical Physics, Clinical Engineering and Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acuros-Based Planning with Density Override for Lung SBRT by a Dynamic Conformal Arc Technique: Comparative Evaluation with AAA-Based Planning in Four-Dimensional Dose\",\"authors\":\"I. Yeo, N. Joyce, Deepinder P. Singh, M. Milano, Yuhchyau Chen, Sanjukta Bandyopadhyay, Hongmei Yang, D. Rosenzweig\",\"doi\":\"10.4236/IJMPCERO.2021.102009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The purpose of this study was to evaluate a planning \\nstrategy based on Acuros with density override in comparison with AAA without \\nand with the override. Ten lung-tumor patients were selected with each PTV size \\naround 2 - 4 cm and were imaged using slow scan, followed by four-dimensional \\n(4D) imaging limited to the target. On each \\nphase-specific image, gross tumor volume (GTV) was contoured. Summed \\nover all phases, an integrated GTV (iGTV) was generated and copied to the slow \\nscan. A treatment plan was created using a dynamic-conformal-arc technique with \\nAAA to prescribe 60 Gy to 95% of PTV (iGTV + 0.5 cm). Each AAA-based plan was \\nregenerated by overriding the density of the setup margin of PTV by GTV density \\n(modeling tumor-position uncertainty). It was also regenerated with Acuros and \\nthe override. The three plans were validated in 4D dose to PTV, after similarly \\noverriding PTV density (phase-specific), accurately calculating with Acuros, \\nand summing the phase-specific plans through organ/dose registration. The \\nAcuros-based plan with the override, the AAA-based plan, and the AAA-based plan \\nwith the override provided 4D PTV doses of 63.9, 67.9, and 62 Gy at D95%, \\nrespectively, averaged over all patients. The override with Acuros and AAA \\nproduced lesser 4D doses, closer to the associated 3D doses, respectively, than \\nthat without the override, with better conformity and inhomogeneity. With the \\noverride in common, Acuros provided a greater dose to PTV than that by AAA. The \\nAcuros with the override, which was more accurate than the AAA without the \\noverride, is clinically recommended.\",\"PeriodicalId\":14028,\"journal\":{\"name\":\"International Journal of Medical Physics, Clinical Engineering and Radiation Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Medical Physics, Clinical Engineering and Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4236/IJMPCERO.2021.102009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Physics, Clinical Engineering and Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/IJMPCERO.2021.102009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本研究的目的是评估一种基于acros的规划策略,并将其与没有和有覆盖的AAA进行比较。选择10例肺肿瘤患者,每个PTV大小约为2 - 4cm,采用慢速扫描成像,然后进行仅限于目标的四维(4D)成像。在每个阶段特异性图像上,勾画出肿瘤总体积(GTV)。对所有相位求和,生成一个集成的GTV (iGTV)并复制到慢速扫描。采用AAA动态共形弧技术制定治疗方案,处方60 Gy至95% PTV (iGTV + 0.5 cm)。通过GTV密度(模拟肿瘤位置不确定性)覆盖PTV设置边界的密度,再生每个基于aaa的平面图。它也被acros和覆盖系统再生了。3种方案以4D剂量对PTV进行验证,同样覆盖PTV密度(阶段特异性),用Acuros精确计算,并通过器官/剂量登记将阶段特异性方案相加。acuros方案加覆盖、aaa方案和aaa方案加覆盖的4D PTV剂量分别为63.9、67.9和62 Gy, D95%为所有患者的平均剂量。acros覆盖组和AAA覆盖组产生的4D剂量比未覆盖组更小,分别更接近相关的3D剂量,具有更好的一致性和非均匀性。在常规覆盖下,acros比AAA提供更大的PTV剂量。临床推荐使用带有覆盖的acros,它比没有覆盖的AAA更准确。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Acuros-Based Planning with Density Override for Lung SBRT by a Dynamic Conformal Arc Technique: Comparative Evaluation with AAA-Based Planning in Four-Dimensional Dose
The purpose of this study was to evaluate a planning strategy based on Acuros with density override in comparison with AAA without and with the override. Ten lung-tumor patients were selected with each PTV size around 2 - 4 cm and were imaged using slow scan, followed by four-dimensional (4D) imaging limited to the target. On each phase-specific image, gross tumor volume (GTV) was contoured. Summed over all phases, an integrated GTV (iGTV) was generated and copied to the slow scan. A treatment plan was created using a dynamic-conformal-arc technique with AAA to prescribe 60 Gy to 95% of PTV (iGTV + 0.5 cm). Each AAA-based plan was regenerated by overriding the density of the setup margin of PTV by GTV density (modeling tumor-position uncertainty). It was also regenerated with Acuros and the override. The three plans were validated in 4D dose to PTV, after similarly overriding PTV density (phase-specific), accurately calculating with Acuros, and summing the phase-specific plans through organ/dose registration. The Acuros-based plan with the override, the AAA-based plan, and the AAA-based plan with the override provided 4D PTV doses of 63.9, 67.9, and 62 Gy at D95%, respectively, averaged over all patients. The override with Acuros and AAA produced lesser 4D doses, closer to the associated 3D doses, respectively, than that without the override, with better conformity and inhomogeneity. With the override in common, Acuros provided a greater dose to PTV than that by AAA. The Acuros with the override, which was more accurate than the AAA without the override, is clinically recommended.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment of Monitor Units and Gamma Pass Rate for 6 MV and Flattening Filter Free (FFF) Beams in Volumetric Modulated Arc Therapy (VMAT) The Journey of SRS: An Initial Experience of Starting Sterotactic Radiosurgery Facility at Purbanchal Cancer Hospital—First in Nepal Hereditary Multiple Exostoses (HME) with Peroneal Nerve Compresion: A Case Report Dosimetric Study of the Effect of Calypso-Compatible Couch Top for Spine Stereotactic Body Radiation Therapy Radiation-Associated Cardiotoxicity during Breast Cancer Treatment with Ionizing Radiation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1